Prehypertension (increased normal blood pressure): to treat or to observe?


Cite item

Full Text

Abstract

The present article discusses the clinical and prognostic significance of prehypertension (increased normal blood pressure). The medical approaches to this condition are considered. If prehypertension is accompanied by high risk of complications and/or signs of target organ lesions, administration of antihypertensive drugs, in the first place, obviously, ACE inhibitors or angiotensin II receptor blockers should be discussed.

References

  1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC VI Report. JAMA 2003;289:2560-71.
  2. ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J. Hypertens 2007;25:1105-18.
  3. Российское Медицинское Общество по Артериальной Гипертонии - Всероссийское Научное Общество Кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр.). М., 2008.
  4. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004;164:2126-34.
  5. Kokubo Y, Kamide K, Okamura T, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita Study. Hypertension 2008;52:652-59.
  6. Toprak A, Wang H, Chen W, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens 2009;27(2):243-50.
  7. Aekplakorn W, Abbott-Klafter J, Khonputsa P, et al. Prevalence and management of prehypertension and hypertension by geographic regions of Thailand: the Third National Health Examination Survey, 2004. J Hypertens 2008;26(2):191-98.
  8. Erem C, Hacihasanoglu A, Kocak M, et al. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf.) 2009;31(1):47-58.
  9. Yang J, Lu F, Zhang C, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010;33(4):331-37.
  10. Ishikawa Y, Ishikawa J, Ishikawa S, et al. Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res 2008;31(7):1323-330.
  11. Kawamoto R, Kohara K, Tabara Y, et al. High prevalence of prehypertension is associated with the increased body mass index in community-dwelling Japanese. Tohoku J Exp Med 2008;216(4):353-61.
  12. Genovesi S, Antolini L, Giussani M, et al. Hypertension, prehypertension, and transient elevated blood pressure in children: association with weight excess and waist circumference. Am. J. Hypertens. 2010 Mar 18. [Epub ahead of print]
  13. Di Bonito P, Forziato C, Sanguigno E, et al. Prehypertension in outpatient obese children. Am J Hypertens 2009;22(12):1309-13.
  14. Yang G, Shu XO, Gao YT, et al. Impacts of weight change on prehypertension in middle-aged and elderly women. Int. J. Obes. (Lond). 2007;31(12):1818-25.
  15. Hwu CM, Liou TL, Hsiao LC, et al. Prehypertension is associated with insulin resistance. Q.J.M. 2009;102(10):705-11.
  16. Anan F, Masaki T, Ono E, et al. Predictors for prehypertension in patients with impaired glucose tolerance. Hypertens Res 2008;31(10):1913-20.
  17. Everett CJ, Frithsen IL. Evidence that prehypertension is a risk factor for Type 2 diabetes. Expert Rev Cardiovasc Ther 2010;8(3):335-7.
  18. Deedwania PC. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr Diab Rep 2003;3(4):289-92.
  19. Мычка В.Б., Чазова И.Е. Основные принципы лечения метаболического синдрома. М., 2009.
  20. Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007;25(8):1583-89.
  21. Liang J, Xue Y, Zou C, et al. Serum uric acid and prehypertension among Chinese adults. J Hypertens 2009;27(9):1761-65.
  22. Мухин Н.А., Балкаров И.М., Шоничев Д.Г. и др. Формирование артериальной гипертонии при хроническом уратном тубуло-интерстициальном нефрите // Терапевтический архив. 1999. № 71(6). С. 23-27.
  23. Pitsavos C, Chrysohoou C, Panagiotakos DB, et al. Abdominal obesity and inflammation predicts hypertension among prehypertensive men and women: the ATTICA Study. Heart Vessels 2008;23(2):96-103.
  24. Leitschuh M, Cupples LA, Kannel W, et al. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991;17(1):22-7.
  25. Liu LK, Peng LN, Chen LK, et al. Prehypertension among middle-aged and elderly people in Taiwan: a five-year follow-up. J Atheroscler Thromb 2010;17(2):189-94.
  26. Jimenez-Corona A, Lopez-Ridaura R, Stern MP, et al. Risk of progression to hypertension in a low-income Mexican population with prehypertension and normal blood pressure. Am J Hypertens 2007;20(9):929-36.
  27. De Marco M, de Simone G, Roman MJ. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension 2009;54(5):974-80.
  28. Sun Z, Zheng L, Detrano R, et al. Risk of progression to hypertension in a rural chinese women population with prehypertension and normal blood pressure. Am J Hypertens 2010 Mar 18. [Epub ahead of print]
  29. Maceneaney OJ, Desouza CA, Weil BR, et al. Prehypertension and endothelial progenitor cell function. J. Hum. Hypertens. 2010 Mar 25. [Epub ahead of print]
  30. Knight EL, Kramer HM, Curhan GС. High-normal blood pressure and microalbuminuria. Am J Kidney Dis 2003;41(3):588-95.
  31. Kim BJ, Lee HJ, Sung KC, et al. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007;71(8):1283-7.
  32. Norton GR, Maseko M, Libhaber E, et al. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent? J Hypertens 2008;26(12):2279-87.
  33. Stabouli S, Kotsis V, Rizos Z, et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol 2009;24(8):1545-51.
  34. Di Bello V, Talini E, Dell'Omo G, et al. Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study. Am J Hypertens 2010;23(4):405-12.
  35. Markus MR, Stritzke J, Lieb W, et al. Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function: the MONICA/KORA Augsburg study. J Hypertens 2008;26(10):2040-9.
  36. Natali A, Muscelli E, Casolaro A, et al. Metabolic characteristics of prehypertension: role of classification criteria and gender. J Hypertens 2009;27(12):2394-402.
  37. Erdogan D, Caliskan M, Yildirim I, et al. Effects of normal blood pressure, prehypertension and hypertension on left ventricular diastolic function and aortic elastic properties. Blood Press 2007;16(2):114-21.
  38. Gedikli O, Kiris A, Ozturk S, et al. Effects of prehypertension on arterial stiffness and wave reflections. Clin Exp Hypertens 2010;32(2):84-9.
  39. Лазебник Л.Б., Звенигородская Л.А., Егорова Е.Г. Метаболический синдром у пациентов с заболеваниями органов пищеварения // Терапевтический архив. 2007. № 79(10). С. 9-13.
  40. Sowers JR. The cardiomethabolic syndrome and liver disease. J Cardiomathab Syndr 2008;3:7-11.
  41. Kawamoto R, Kohara K, Tabara Y, et al. Association between serum gamma-glutamyl transferase level and prehypertension among community-dwelling men. Tohoku J Exp Med 2008;216(3):213-21.
  42. Gu Q, Burt VL, Paulose-Ram R, et al. High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 2008;18(4):302-9.
  43. Gu D, Chen J, Wu X, et al. Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens 2009;27(4):721-9.
  44. Pletcher M.J., Bibbins-Domingo K., Lewis K. et al. Prehypertension during young adulthood and coronary calcium later in life: the Coronary Artery Risk Development in Young Adults Study. Ann Intern Med 2008;149(2):91-9.
  45. Hozawa A, Kuriyama S, Kakizaki M, et al. Attributable risk fraction of prehypertension on cardiovascular disease mortality in the Japanese population: the Ohsaki Study. Am J Hypertens 2009;22(3):267-72.
  46. Kiely AE, Kwatra SG, Kwatra MM. Treating prehypertension: medically sound and economically viable. Blood Press 2009;18(6):300-3.
  47. Bavikati VV, Sperling LS, Salmon RD, et al. Effect of comprehensive therapeutic lifestyle changes on prehypertension. Am J Cardiol 2008;102(12):1677-80.
  48. Karanja N, Lancaster KJ, Vollmer WM, et al. Acceptability of sodium-reduced research diets, including the Dietary Approaches To Stop Hypertension diet, among adults with prehypertension and stage 1 hypertension. J Am Diet Assoc 2007;107(9):1530-8.
  49. Blumenthal JA, Babyak MA, Hinderliter A, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010;170(2):126-35.
  50. The Heart Outcomes Prevention Evaluation Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
  51. Lüders S, Schrader J, Berger J, et al.; PHARAO Study Group. The PHARAO study: prevention of hypertension with the angiotensin converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens 2008;26(7):1487-96.
  52. Julius S, Nesbitt SD, Egan BM, et al.; Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354(16):1685-97.
  53. Williams SA, Michelson EL, Cain VA, et al.; TROPHY Study Investigators. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J. Clin. Hypertens. (Greenwich) 2008;10(6):436-42.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies